The upcoming Hit ID Symposium will be held on 27 October 2023 at the Woodward Conference Centre, in Melbourne, Australia. This event will consist of scientific sessions, interactive events and networking opportunities focussed on introducing delegates to the topic of hit identification within a small molecule drug discovery setting.

This is the first small molecule drug discovery symposium showcasing the hit identification infrastructure available within Melbourne’s Parkville precinct, with a series of drug development success stories. The event provides a unique opportunity to be involved in a wide-reaching symposium that will focus on hit-finding screening campaigns in drug discovery, delivered by experts actively working in the field from both within academia and industry.

Tom Mander, our CEO, will be there.